How I treat MSI cancers with advanced disease
Main Authors: | John Haanen, Marleen Kok, Myriam Chalabi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-05-01
|
Series: | ESMO Open |
Online Access: | https://esmoopen.bmj.com/content/4/Suppl_2/e000511.full |
Similar Items
-
Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
by: Robin Park, et al.
Published: (2021-04-01) -
Comparing DESI-MSI and MALDI-MSI Mediated Spatial Metabolomics and Their Applications in Cancer Studies
by: Michelle Junyi He, et al.
Published: (2022-07-01) -
530 Clinicopathologic features and outcome of patients with microsatellite instable (MSI-H) cancer treated in a Phase I unit
by: Carmen Criscitiello, et al.
Published: (2023-11-01) -
Basic digital electronics with MSI applications /
by: 415779 Dempsey, John A.
Published: (1977) -
Knockout of RNA Binding Protein MSI2 Impairs Follicle Development in the Mouse Ovary: Characterization of MSI1 and MSI2 during Folliculogenesis
by: Jessie M. Sutherland, et al.
Published: (2015-06-01)